{"product_id":"liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation","title":"Liquid NAD+ Anti-Aging Drink | NR Berry Stick Packs for NAD+ \u0026 Sirtuin Support","description":"\u003cp\u003e\u003cstrong\u003eNAD+ precursors in drinkable form\u003c\/strong\u003e — built for people who don't want to swallow more capsules, who already have a morning routine where adding a drink is easier than adding another pill bottle, and who travel and don't want a carry-on stuffed with HDPE bottles. Single-serve berry stick packet, dissolves in 30 seconds in 7–10 oz of cold water, no scoops, no measuring, TSA-friendly, no artificial colors, no added sugar bombs. Same NAD+-pathway biology as our \u003ca href=\"\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e — just delivered through the format you'll actually take every single day.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink format, soluble delivery\u003c\/strong\u003e — absorption begins in the oral mucosa and continues through the upper GI without waiting on capsule disintegration. Powder dissolved in 7–10 oz cold water reaches plasma faster than the equivalent dose of compressed capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) at the center\u003c\/strong\u003e — the NAD+ precursor with the longest human clinical-trial track record. Trial-validated daily dosing (Trammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e, Conze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e, Martens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e, Brakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e NADPARK).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClean berry flavor, no sweet bombs\u003c\/strong\u003e — no artificial colors, no sucralose, no stevia avalanche; mixes cleanly so it doesn't taste medicinal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-serve packets\u003c\/strong\u003e — TSA-friendly, no scoops, no measuring spoons, no spilling powder in your kitchen drawer. Stable at room temperature, single-use foil-laminated packaging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundation-tier daily NAD+ support\u003c\/strong\u003e — pairs cleanly with \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e, \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e, and the rest of the longevity stack — never redundant with capsules; many users alternate or stack the formats.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who don't tolerate capsules well, those building a morning-drink ritual, anyone who finds drink supplements easier to remember than pill bottles, frequent travelers, and users who want NAD+ pathway support that's literally pleasant to take.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NAD+ matters — the foundational coenzyme behind cellular aging\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is one of the most foundational coenzymes in human biology. Every nucleated cell in your body uses it. It runs the electron transport chain in your mitochondria — the system that converts food and oxygen into ATP, the molecular currency of energy. It is the obligate substrate of the \u003cstrong\u003esirtuin family\u003c\/strong\u003e of NAD+-dependent deacetylases (SIRT1–SIRT7), which silence pro-aging gene programs, regulate inflammation, drive DNA-damage response, and govern mitochondrial biogenesis. It powers the \u003cstrong\u003ePARP enzymes\u003c\/strong\u003e that detect and repair single- and double-strand DNA breaks every day. It is consumed by \u003cstrong\u003eCD38\u003c\/strong\u003e, the cell-surface ectoenzyme whose age-related upregulation is one of the largest mechanistic explanations for falling NAD+ pools (Camacho-Pereira 2016 \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, none of these systems run properly.\u003c\/p\u003e\n\n\u003cp\u003eThe problem: NAD+ levels drop sharply with age. Massudi 2012 (\u003cem\u003ePLOS ONE\u003c\/em\u003e) showed roughly a \u003cstrong\u003e~50% decline in skin NAD+ between the 20s and 50s\u003c\/strong\u003e with the decline accelerating after that. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated this multi-tissue in mouse models — liver, muscle, pancreas, white adipose tissue, brown adipose tissue, brain — with parallel declines in NAMPT (the rate-limiting salvage-pathway enzyme). Camacho-Pereira 2016 mapped the decline mechanistically to age-related CD38 upregulation acting as an NAD+ \"sink\" rather than to NAMPT alone. By the time most people notice \"feeling older\" — slower recovery, less morning energy, fuzzier focus, less stress resilience — NAD+ depletion is already one of the underlying biochemical drivers, sitting upstream of the López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e hallmarks of aging (mitochondrial dysfunction, deregulated nutrient sensing, genomic instability, cellular senescence) and folded explicitly into the López-Otín 2023 \u003cem\u003eCell\u003c\/em\u003e integrated-hallmarks update.\u003c\/p\u003e\n\n\u003cp\u003eYou can't supplement NAD+ directly very efficiently in most oral formats — the molecule is too large and polar to cross plasma membranes intact at meaningful doses. That's why the field moved to \u003cstrong\u003eprecursors\u003c\/strong\u003e: smaller molecules (NR, NMN, niacinamide, niacin) that your cells convert into NAD+ on the inside via well-mapped enzymatic routes. NR is the precursor with the most published human-clinical-trial evidence at this point — covering whole-blood NAD+ rise, cardiovascular endpoints, brain NAD+, muscle NAD+, insulin sensitivity, and exercise physiology. It is the active core of this drink.\u003c\/p\u003e\n\n\u003cp\u003eFor a deeper introduction read \u003ca href=\"\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e and \u003ca href=\"\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhy drink format — not just preference, real biology\u003c\/h2\u003e\n\u003cp\u003eCapsules and drink mixes are not biologically equivalent on day one of dosing. Three things change when you take an NAD+ precursor as a dissolved drink instead of a hard capsule:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOnset\u003c\/strong\u003e. A hard-shell HPMC capsule needs 5–15 minutes to disintegrate in the stomach before the contents become available for absorption (USP \u0026lt;701\u0026gt; disintegration spec is ≤30 minutes for HPMC capsules; in practice typically 5–12 minutes). A dissolved drink presents the precursor to the intestinal mucosa within 30 seconds. This narrows the gap between \"taking the supplement\" and \"the molecule arriving at the absorption surface\" to roughly the gastric-emptying half-time of liquid (10–20 minutes for water on an empty stomach).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuccal and upper-GI absorption\u003c\/strong\u003e. NR has been shown to absorb partially via the oral mucosa and proximal small intestine via the equilibrative nucleoside transporters ENT1 and ENT2 (Ratajczak 2016 \u003cem\u003eNat Commun\u003c\/em\u003e). A dissolved drink is in contact with absorptive surfaces immediately; a capsule is not.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdherence — the variable that dwarfs everything else\u003c\/strong\u003e. The single largest determinant of long-term outcomes from any daily supplement is whether you actually take it every day for months. Trial endpoints in NAD+ research (Conze 2019, Brakedal 2022 NADPARK 1g\/day for 30 weeks, Pirinen 2020 1g\/day for 4 months) require \u003cem\u003eweeks-to-months\u003c\/em\u003e of compliance. Capsule fatigue, capsule aversion, \"I forgot, I'll do it tomorrow\" — these account for far more lost benefit than any pharmacokinetic difference between formats. A drink that's actually pleasant to take every morning beats a capsule that ends up rationed.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThis product isn't trying to replace capsule NAD+ precursors — it's the format that wins for a specific user. If you already happily take capsules, our \u003ca href=\"\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e remain the highest-density precursor delivery per dollar. If you have capsule fatigue, swallowing aversion, traveler-luggage limits, or a strong morning-drink ritual where adding one stick packet is invisible, this format quietly wins on adherence — the variable that matters most.\u003c\/p\u003e\n\n\u003ch2\u003eWhy Nicotinamide Riboside (NR) specifically\u003c\/h2\u003e\n\u003cp\u003eThe four NAD+ precursors a cell can use are \u003cstrong\u003eNR (Nicotinamide Riboside)\u003c\/strong\u003e, \u003cstrong\u003eNMN (Nicotinamide Mononucleotide)\u003c\/strong\u003e, \u003cstrong\u003eNAM (Niacinamide \/ Nicotinamide)\u003c\/strong\u003e, and \u003cstrong\u003eNA (Niacin \/ Nicotinic Acid)\u003c\/strong\u003e. Each has trade-offs:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — phosphorylated to NMN by NRK1\/NRK2 (Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e), then adenylylated to NAD+ by NMNAT1\/2\/3. Crosses cell membranes intact via ENT1\/2 (Ratajczak 2016). Most extensively human-trialed precursor (Trammell 2016, Conze 2019, Martens 2018, Dollerup 2018, Elhassan 2019, Brakedal 2022, Pirinen 2020, Dellinger 2017). No flushing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one step closer to NAD+ but reportedly enters cells via the proposed Slc12a8 transporter (Grozio 2019 \u003cem\u003eNature Metabolism\u003c\/em\u003e) or via extracellular conversion to NR by CD73 then re-uptake. Strong human-trial bench at the 250–1000mg dose range (Yoshino 2021 \u003cem\u003eScience\u003c\/em\u003e, Yi 2022, Liao 2021, Igarashi 2022). Functionally interchangeable with NR for most users; many longevity practitioners stack both to hedge across the parallel salvage entry points.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAM\u003c\/strong\u003e — cheap, abundant, but at high doses inhibits sirtuins (Bitterman 2002 \u003cem\u003eJBC\u003c\/em\u003e) by acting as a product-inhibitor. Useful as a B3-vitamin source; less ideal as a sirtuin-substrate booster.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNA\u003c\/strong\u003e — raises NAD+ but causes prostaglandin-mediated flushing at meaningful doses unless given as ER-niacin under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNR is the precursor with the densest human evidence base at this dose range, the cleanest tolerability profile, and parallel absorption pathways (ENT1\/2 plus CD73→NR conversion) that make it format-flexible for liquid delivery. That's why it sits at the center of this drink.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — how NR becomes NAD+ inside your cells\u003c\/h2\u003e\n\u003cp\u003eNR taken orally has the following well-mapped fate (Ratajczak 2016, Trammell 2016, Cantó 2015 \u003cem\u003eCell Metabolism\u003c\/em\u003e):\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Absorption.\u003c\/strong\u003e NR is absorbed in the oral mucosa, stomach, and proximal small intestine via the equilibrative nucleoside transporters \u003cstrong\u003eENT1\u003c\/strong\u003e and \u003cstrong\u003eENT2\u003c\/strong\u003e (encoded by SLC29A1 \/ SLC29A2). It does not require the proposed Slc12a8 transporter that NMN appears to use. Plasma NR rises within 30–120 minutes; whole-blood NAD+ rises within 8 hours and remains elevated for 24+ hours after a single dose (Trammell 2016, Conze 2019).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NRK1\/NRK2 phosphorylation.\u003c\/strong\u003e Inside the cell, NR is phosphorylated to NMN by the NR kinases NRK1 (ubiquitous) and NRK2 (tissue-restricted to muscle, heart, brain). This step was discovered and characterized in Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e. NRK1 expression is the primary rate-limiting determinant of how quickly a given tissue converts NR to NAD+.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. NMNAT1\/2\/3 adenylylation.\u003c\/strong\u003e NMN is then adenylylated to NAD+ by the three nicotinamide mononucleotide adenylyltransferase isoforms — NMNAT1 (nucleus), NMNAT2 (Golgi\/cytosol), NMNAT3 (mitochondria). This step compartmentalizes NAD+ synthesis to where it's needed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Mitochondrial uptake.\u003c\/strong\u003e Mitochondrial NAD+ uptake is governed by the \u003cstrong\u003eSLC25A51\u003c\/strong\u003e transporter, identified in 2020 by Luongo et al. (\u003cem\u003eNature\u003c\/em\u003e). This was the answer to one of the longest-standing questions in NAD+ biology — how the cytosolic and mitochondrial NAD+ pools communicate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Consumption.\u003c\/strong\u003e NAD+ is consumed by three classes of enzymes: \u003cstrong\u003esirtuins\u003c\/strong\u003e (SIRT1–SIRT7) deacetylate substrate proteins using NAD+ as cofactor; \u003cstrong\u003ePARPs\u003c\/strong\u003e (PARP1, PARP2, etc.) consume NAD+ during DNA-damage repair; and \u003cstrong\u003eCD38\u003c\/strong\u003e hydrolyzes NAD+ at a stoichiometry of roughly 100 NAD+ molecules per cyclic-ADP-ribose product. CD38 is the dominant age-related sink (Camacho-Pereira 2016) — which is why \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e (a flavonoid CD38 inhibitor; Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e) is a logical stack partner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Salvage and methylation.\u003c\/strong\u003e NAM — the byproduct of every sirtuin\/PARP\/CD38 NAD+-consuming reaction — is recycled back to NMN by NAMPT, the rate-limiting salvage-pathway enzyme. Excess NAM is methylated to 1-MNA (1-methylnicotinamide) by NNMT, drawing from the SAM (S-adenosylmethionine) methylation pool. This is why methyl-donor support — \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e — pairs with daily NR\/NMN dosing, especially at higher doses (1g+\/day) and for users with MTHFR variants or marginal B12 status. 1-MNA appearance in urine is the standard pharmacodynamic biomarker confirming NAD+ flux is occurring (Trammell 2016).\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence base for NR\u003c\/h2\u003e\n\u003cp\u003eNR has the densest human-trial bench of any NAD+ precursor. Selected trials at doses spanning 100mg – 3000mg\/day:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eTrial\u003c\/th\u003e\n      \u003cth\u003ePopulation\u003c\/th\u003e\n      \u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n      \u003cth\u003ePrimary findings\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eTrammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 healthy adults (single-dose PK)\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg single dose\u003c\/td\u003e\n      \u003ctd\u003eDose-dependent rise in whole-blood NAD+ within 8h sustained 24h. 1-MNA urinary appearance confirms flux. No AEs.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eConze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e140 healthy adults\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear whole-blood NAD+ rise: ~22% \/ 51% \/ 142% at the three doses. No AEs different from placebo.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMartens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e24 healthy adults 55–79\u003c\/td\u003e\n      \u003ctd\u003e500mg twice daily × 6wk\u003c\/td\u003e\n      \u003ctd\u003eWhole-blood NAD+ +60%, ~10mmHg systolic-BP drop in elevated-BP subgroup, aortic-stiffness reduction trend.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDellinger 2017 \u003cem\u003eNPJ Aging\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e120 adults 60–80 (NRPT combination NR+pterostilbene)\u003c\/td\u003e\n      \u003ctd\u003e250\/500mg NR + 50\/100mg pterostilbene × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear NAD+ rise; secondary ALT\/AST reduction in the high-dose arm.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDollerup 2018 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e40 obese, insulin-resistant men\u003c\/td\u003e\n      \u003ctd\u003e1000mg twice daily × 12wk\u003c\/td\u003e\n      \u003ctd\u003eNAD+ pathway elevation; no significant change in primary insulin-sensitivity outcome (well-tolerated).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eElhassan 2019 \u003cem\u003eCell Reports\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 elderly men 70–80\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 21d\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; reduced inflammatory cytokines (IL-6, IL-5, IL-2); improved muscle bioenergetics.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRemie 2020 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e13 healthy overweight men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 6wk crossover\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ +15%; sleep efficiency increase signal (small-N exploratory).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n      \u003ctd\u003e30 newly-diagnosed Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 30d (placebo-controlled)\u003c\/td\u003e\n      \u003ctd\u003eCSF NAD+ rise; brain NAD+ rise on PET; secondary clinical-rating improvement signal.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2023 \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n      \u003ctd\u003e20 Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e3000mg\/day × 4wk\u003c\/td\u003e\n      \u003ctd\u003eSafety\/tolerability extension trial. No serious AEs at 3g\/day; established the upper-dose ceiling for human safety.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePirinen 2020 \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e5 adult-onset mitochondrial myopathy patients\u003c\/td\u003e\n      \u003ctd\u003e250–1000mg\/day × 4 months\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; mitochondrial-myopathy biomarker improvement; case-series-grade evidence in a rare disease cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eStocks 2021 \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e14 healthy older men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; no change in mitochondrial respiration in this small healthy cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAirhart 2017 \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e8 healthy adults (PK\/safety)\u003c\/td\u003e\n      \u003ctd\u003e250mg\/day × 7d, 500mg\/day × 7d, etc.\u003c\/td\u003e\n      \u003ctd\u003eStepped dose-escalation tolerability and PK profile.\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRead together: NR is one of the few longevity-positioned compounds where the human evidence base actually maps cleanly onto the mechanistic story. NAD+ rises (Trammell, Conze, Brakedal, Elhassan), tissue penetration is documented (muscle in Elhassan\/Remie\/Stocks; CSF\/brain in Brakedal NADPARK), cardiovascular signal exists (Martens 2018), safety is established up to 3g\/day (Brakedal 2023 NR-SAFE), and the mechanism (NRK1→NMN→NAD+) is structurally proven. That's why NR is the active core of this drink — not because it's the only NAD+ precursor that works, but because it has the most complete human evidence base at this dose range.\u003c\/p\u003e\n\n\u003ch2\u003eDrink-format NAD+ — comparing what's actually on the market\u003c\/h2\u003e\n\u003cp\u003eOnce you commit to drink format, the next question is what kind. Six paths exist:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eFormat\u003c\/th\u003e\n      \u003cth\u003eActive\u003c\/th\u003e\n      \u003cth\u003eOnset\u003c\/th\u003e\n      \u003cth\u003eTrial coverage\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis product (NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eNR\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 8h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eMost-trialed precursor\u003c\/td\u003e\n      \u003ctd\u003eDaily morning ritual, travel, capsule-aversion users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNMN powder (loose)\u003c\/td\u003e\n      \u003ctd\u003eNMN\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 5h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eStrong (Yoshino, Yi, Igarashi, Liao)\u003c\/td\u003e\n      \u003ctd\u003eUsers who want NMN’s one-step-closer position\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSublingual lozenges\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e5–10min dissolve\u003c\/td\u003e\n      \u003ctd\u003eLimited; absorption claims rarely PK-verified\u003c\/td\u003e\n      \u003ctd\u003eUsers who specifically want sublingual, willing to accept thinner trial bench\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMulti-ingredient drink (this product’s sister: \u003ca href=\"\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink\u003c\/a\u003e)\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/td\u003e\n      \u003ctd\u003e30s mix → combined-stack effect\u003c\/td\u003e\n      \u003ctd\u003eEach ingredient trialed individually\u003c\/td\u003e\n      \u003ctd\u003eUsers who want a single morning drink covering precursor + sirtuin activator + mitochondrial cofactor + senolytic in one packet\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNAD+ IV therapy\u003c\/td\u003e\n      \u003ctd\u003eNAD+ direct\u003c\/td\u003e\n      \u003ctd\u003e~3–8h infusion\u003c\/td\u003e\n      \u003ctd\u003eLimited published; mostly observational\u003c\/td\u003e\n      \u003ctd\u003eAcute high-dose use; not for daily-foundation positioning\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCapsule NR or NMN\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e10–20min capsule disintegration + GI absorption\u003c\/td\u003e\n      \u003ctd\u003eDensest trial bench (capsules are what's used in most published trials)\u003c\/td\u003e\n      \u003ctd\u003eUsers with no capsule aversion, fewest moving parts\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this drink sits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ line was built so each product owns a distinct spot in the precursor \/ activator \/ cofactor \/ convenience space — not as duplicates. The seven distinct entry points:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eProduct\u003c\/th\u003e\n      \u003cth\u003eForm\u003c\/th\u003e\n      \u003cth\u003ePrimary role\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis drink (Liquid NAD+ NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, single-serve\u003c\/td\u003e\n      \u003ctd\u003eNR delivery in drink format\u003c\/td\u003e\n      \u003ctd\u003eCapsule-aversion, morning ritual, travel\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink Mix\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, multi-ingredient\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin combo\u003c\/td\u003e\n      \u003ctd\u003eOne-drink-covers-everything users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNR + B-vitamin cofactors\u003c\/td\u003e\n      \u003ctd\u003eCapsule-comfortable users; densest precursor delivery per dollar\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at trial-validated entry dose\u003c\/td\u003e\n      \u003ctd\u003eNMN-pathway preference; entry tier\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at upper trial dose\u003c\/td\u003e\n      \u003ctd\u003eHigher-dose NMN protocol; pairs with TMG\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ + Trans-Resveratrol\u003c\/td\u003e\n      \u003ctd\u003eSirtuin-substrate + activator pair in one capsule\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eLiposomal capsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ via phospholipid encapsulation\u003c\/td\u003e\n      \u003ctd\u003eUsers who want phospholipid-protected delivery\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN + CoQ10 + B-Complex + Antioxidants + Skin support\u003c\/td\u003e\n      \u003ctd\u003eOne-capsule-stack convenience users\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the right answer is \u003cstrong\u003eone drink-format product\u003c\/strong\u003e for the morning ritual + \u003cstrong\u003eone sirtuin activator\u003c\/strong\u003e (Resveratrol or Pterostilbene) + \u003cstrong\u003emethyl-donor support\u003c\/strong\u003e (TMG) + the rest of the foundational stack (Magnesium, Vit-D, Omega-3). Browse the full NAD+ Family at \u003ca href=\"\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability deep-dive — what we know about drink-format NR PK\u003c\/h2\u003e\n\u003cp\u003eThe published NR pharmacokinetic profile (Trammell 2016, Airhart 2017, Conze 2019) was established in capsule and powder formats. Key findings translate to drink delivery:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR\u003c\/strong\u003e peaks 30–120 minutes after oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+\u003c\/strong\u003e rises within 8 hours and remains elevated 24+ hours after a single dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-linearity\u003c\/strong\u003e documented in Conze 2019 across 100\/300\/1000mg\/day × 8wk: ~22% \/ 51% \/ 142% NAD+ rise respectively. The dose-response is approximately log-linear in this range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1-MNA urinary appearance\u003c\/strong\u003e rises within 24 hours, confirming the NAD+→NAM→1-MNA flux is occurring (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSteady-state\u003c\/strong\u003e NAD+ elevation is reached by approximately week 1–2 of daily dosing; further dosing maintains rather than progressively elevates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue distribution\u003c\/strong\u003e documented in muscle (Elhassan, Remie, Stocks), CSF\/brain (Brakedal NADPARK), and liver (preclinical). Mitochondrial NAD+ rise is governed by SLC25A51 capacity (Luongo 2020 \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDrink-format delivery vs capsule delivery should not change steady-state NAD+ levels over weeks — both end up at the same plateau if dosed daily — but it does compress the time-to-onset of each individual dose, and (more importantly for outcomes) it materially raises the probability that you actually take it every day.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — what to pair with daily NAD+ drink\u003c\/h2\u003e\n\u003cp\u003eNR alone raises NAD+ but doesn't address the consumer side (CD38), the sirtuin-activator side (resveratrol\/pterostilbene), or the methylation tax (TMG). The mechanistically-coherent stack:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair\u003c\/h3\u003e\n\u003cp\u003eNR\/NMN provides the substrate. Sirtuin-activating compounds — \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e; Park 2012 \u003cem\u003eCell\u003c\/em\u003e; Lagouge 2006 \u003cem\u003eCell\u003c\/em\u003e) and \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e (Riche 2014 trial) — allosterically activate SIRT1. Pair the NAD+ precursor drink with one of these. This is the “Sinclair-style” canonical longevity pairing.\u003c\/p\u003e\n\n\u003ch3\u003eMethylation support\u003c\/h3\u003e\n\u003cp\u003eNAM — the byproduct of every sirtuin reaction — is methylated to 1-MNA by NNMT, drawing on the SAM pool. \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e donates a methyl group to homocysteine, regenerating methionine and protecting the SAM pool (Olthof 2003 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; McRae 2013 \u003cem\u003eCardiol Res Pract\u003c\/em\u003e). Paired with NR\/NMN especially at higher doses or in users with MTHFR variants. \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e is a parallel methyl-buffer.\u003c\/p\u003e\n\n\u003ch3\u003eCD38 reduction\u003c\/h3\u003e\n\u003cp\u003eCD38 is the dominant age-related NAD+ sink (Camacho-Pereira 2016). Flavonoid CD38 inhibitors — \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e), \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e — reduce the consumer side of the equation. Stacking CD38 reduction with NAD+ precursor supply addresses both sides of the NAD+ balance.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial layer\u003c\/h3\u003e\n\u003cp\u003eNAD+ runs the electron-transport chain. \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e shuttles electrons from Complex I\/II to Complex III. \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis via PGC-1α. \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e activates PINK1\/Parkin-driven mitophagy — clearing dysfunctional mitochondria so the new biogenesis isn't replacing them with damaged copies. \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000mg\u003c\/a\u003e feeds the TCA cycle. Together this is the mitochondrial-renewal layer.\u003c\/p\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e initiates autophagy via eIF5A hypusination (Zhang 2019 \u003cem\u003eMol Cell\u003c\/em\u003e) and EP300 inhibition (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e). Reciprocal with NAD+ precursors — SIRT1 deacetylates autophagy proteins ATG5\/ATG7\/LC3 (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e); spermidine independently triggers the autophagy machinery. Not redundant.\u003c\/p\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e activates AMPK (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). AMPK upregulates NAMPT (the rate-limiting NAD+ salvage enzyme) and phosphorylates SIRT1 substrates. Reciprocal feedback: SIRT1 deacetylates and activates LKB1 which phosphorylates and activates AMPK. The two pathways amplify each other.\u003c\/p\u003e\n\n\u003ch3\u003eAntioxidant + glutathione\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e form the GlyNAC stack (Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e) — restores glutathione synthesis in older adults whose mitochondrial GSH is depleted. \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e recycles vitamin C and glutathione. \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e is the membrane-protected ascorbate. \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e is the membrane-resident lipid-soluble antioxidant.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational layer\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e, \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e, \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e, \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e, \u003ca href=\"\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e. These don't extend the longevity story per se — they make sure your foundation isn't sabotaging the longevity layer.\u003c\/p\u003e\n\n\u003ch3\u003eSkin \/ collagen pairing\u003c\/h3\u003e\n\u003cp\u003eIf skin appearance is an outcome you care about: \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e + \u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg + Vit C\u003c\/a\u003e + \u003ca href=\"\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e form the substrate \/ hydration \/ cofactor stack the \u003ca href=\"\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e bundle was built around. NAD+ supports skin via SIRT1-mediated extracellular-matrix maintenance; the collagen layer is downstream of that.\u003c\/p\u003e\n\n\u003cp\u003eFor a built version of this stack as a single bundle, see the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e or the \u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cp\u003eNAD+ pathway support is built on consistency. Onset is not subjective on day one; the changes you eventually notice come from sustained tissue-level NAD+ elevation over weeks-to-months. Anchored to the published trial timepoints:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1 – week 1.\u003c\/strong\u003e Whole-blood NAD+ rises within 8 hours of the first dose (Trammell 2016) and steady-states by approximately day 7–14 (Conze 2019, Airhart 2017). Most users do not feel anything subjective in this window. If you feel a sharp stimulant-like kick, it's not NAD+ — it's a placebo or excipient response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Some users report subtle morning-energy \/ less afternoon-crash signal as mitochondrial NAD+ elevates and the SLC25A51-governed compartment fills. This is highly variable. Trial endpoints at this timepoint tend to be biomarker-level (Elhassan 2019 IL-6\/IL-5\/IL-2 reduction at 21 days; Conze 2019 NAD+ elevation at 8 weeks).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8.\u003c\/strong\u003e Functional outcomes start to appear in the trial bench: Martens 2018 cardiovascular signal at 6 weeks (~10mmHg SBP drop in elevated-BP subgroup, aortic-stiffness reduction); Igarashi 2022 functional outcomes (SARC-F, 5x sit-to-stand) at 12 weeks. Subjectively users often report better recovery from exercise, better sleep depth, more stable energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12.\u003c\/strong\u003e Trial-published endpoints in this window include cardiovascular (Martens), glucose handling (Yoshino 2021 NMN parallel; Dollerup 2018 NR), sleep, cognitive subjective (Kim 2022 NMN parallel). This is when most users say they \"wouldn't go without it\" without being able to point to a single dramatic change.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3–6 months.\u003c\/strong\u003e Sustained pathway support; this is where the López-Otín hallmarks-of-aging integration is theorized to compound. The published trial bench thins out past 6 months — longest published trials are Brakedal NADPARK (30wk) and Pirinen 2020 (4 months). Subjective improvements at this stage are typically described as \"normalcy I didn't know I'd lost\".\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6+ months.\u003c\/strong\u003e Long-term safety established up to 3g\/day (Brakedal 2023 NR-SAFE) and 2g\/day for 14 days (Pencina 2023 NMN parallel). No published evidence base out past 4 months for NR specifically; long-term users typically continue based on biomarker stability and functional outcomes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStop dosing.\u003c\/strong\u003e Whole-blood NAD+ returns toward baseline within ~30 days of cessation (Conze 2019). This is one of the cleaner reasons NAD+ pathway support is positioned as a daily foundation rather than a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e a daily-foundation NAD+ precursor delivered in a format you'll actually take. The drink-mix path to NR's well-established human-trial benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a stimulant. Don't expect a coffee-like kick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a treatment for any disease. It is a dietary supplement; statements have not been evaluated by FDA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a one-month experiment that will visibly transform you. The trial bench requires weeks-to-months for endpoint readouts.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sleep aid. SIRT1 has indirect circadian-rhythm interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e SIRT1-BMAL1\/CLOCK) but NR is not a sedative; if sleep is the primary goal, see Magnesium Glycinate or Glycine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a substitute for the foundational layer. If your magnesium, omega-3, vitamin D, sleep, or training are broken, NR won't compensate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e redundant with our NR Hard Capsules — it's a delivery-format alternative for users who prefer drinks. Many users alternate or stack the two.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sirtuin activator on its own. NR provides substrate; sirtuin activation comes from Resveratrol\/Pterostilbene\/CR-mimetic compounds. The full benefit is the \u003cem\u003epair\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published functional endpoints land in weeks 6–12. Quitting early loses the benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NAD+ is a cofactor, not a stimulant. The change is subtle, sustained, and biomarker-level — not a rush.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support at higher doses.\u003c\/strong\u003e If you're at ≥500mg\/day NR plus an additional NMN dose, the methylation pool draws down. Add \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without sirtuin activator.\u003c\/strong\u003e Substrate without activator captures only part of the benefit. Pair with \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking NAD+ on a broken foundation.\u003c\/strong\u003e If sleep is \u0026lt;6h, magnesium status is poor, training is absent, and stress-cortisol is unmanaged, NAD+ pathway support is not the highest-leverage thing you can fix.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDosing late in the day.\u003c\/strong\u003e Igarashi 2022 (NMN parallel) found AM dosing \u0026gt; PM dosing on functional endpoints. Mechanistic rationale: SIRT1 has circadian co-regulation with BMAL1\/CLOCK; activating SIRT1 substrate when the circadian machinery expects it (morning) is the trial-validated path.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStoring in humid environments.\u003c\/strong\u003e Single-serve foil packets are stable, but bulk-cut open packets exposed to humidity will gradually degrade. Use within the dose interval, store unused packets cool and dark.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, ideally before breakfast or with first water of the day. Aligns with circadian SIRT1 activity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 stick packet daily. Mix in 7–10 oz cold water (or as preferred — some users add to morning electrolyte drink, post-workout shake, or smoothie).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasted:\u003c\/strong\u003e Either works. NR absorption is not strongly food-dependent. If you experience mild GI upset on an empty stomach, take with food.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e A sirtuin activator (\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e or \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e) taken with a fat-containing meal for best absorption. \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e for methylation support if dosing ≥500mg total daily NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsistency vs. timing:\u003c\/strong\u003e Daily dosing matters far more than which hour you take it. Pick a time you'll keep.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Skip and resume next day. Don't double-dose to \"catch up.\" Steady-state NAD+ is robust to single missed doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e Single-serve foil packets are TSA-friendly in carry-on. No bottle, no scoop, no measuring. One of the format's strongest practical advantages.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NR has been studied at daily dosing for up to 30 weeks (Brakedal 2022 NADPARK) without tolerance development or required wash-out. Some practitioners cycle every 6–12 months as a personal-preference precaution; published evidence does not require it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Months-to-years. NAD+ pathway support is a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ wanting daily NAD+ pathway support without committing to another capsule bottle.\u003c\/li\u003e\n  \u003cli\u003eAnyone with capsule fatigue or swallowing aversion.\u003c\/li\u003e\n  \u003cli\u003eTravelers who want NAD+ support that fits in a luggage pocket.\u003c\/li\u003e\n  \u003cli\u003eUsers who already have a morning-drink ritual (electrolytes, greens, coffee) where adding a stick packet is invisible.\u003c\/li\u003e\n  \u003cli\u003eCapsule users who occasionally want to alternate format.\u003c\/li\u003e\n  \u003cli\u003ePre-workout users who want NAD+ support before training (mitochondrial \/ energy positioning).\u003c\/li\u003e\n  \u003cli\u003eVegan and gluten-free users (no animal-derived ingredients, no gluten in formulation).\u003c\/li\u003e\n  \u003cli\u003eUsers building or maintaining a longevity stack who want one of the seven NAD+ entry points to be drink-format.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or breastfeeding women (insufficient safety data for pregnancy).\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (no pediatric trial data).\u003c\/li\u003e\n  \u003cli\u003eUsers on chemotherapy or active cancer treatment without oncology consultation (NAD+ supports cell proliferation pathways; coordinate with oncology).\u003c\/li\u003e\n  \u003cli\u003eUsers seeking acute high-dose NAD+ delivery (IV therapy is a different category).\u003c\/li\u003e\n  \u003cli\u003eUsers with severe MTHFR variants who can't tolerate methyl loads — pair carefully with TMG and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003eUsers seeking same-day stimulant-like effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, contraindications, interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer \/ chemotherapy:\u003c\/strong\u003e Coordinate with oncology. NAD+ supports proliferative pathways; the literature on NAD+ precursor + cancer is mixed and context-dependent (Yaku 2018 \u003cem\u003eFront Oncol\u003c\/em\u003e review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants:\u003c\/strong\u003e No direct NR-anticoagulant interaction documented, but if stacked with Resveratrol (mild antiplatelet effect) advise caution and physician input. Stop 7–14 days pre-surgery as a general supplement-stack precaution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives:\u003c\/strong\u003e Martens 2018 showed ~10mmHg systolic-BP drop in elevated-BP subgroup. If on antihypertensive medication, monitor and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications:\u003c\/strong\u003e NR has shown insulin-sensitization signal in some trials. Monitor blood glucose if on insulin or sulfonylureas; coordinate with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePsychiatric \/ sleep medications:\u003c\/strong\u003e No direct interaction documented. Indirect SIRT1-circadian effects are subtle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMTHFR \/ methylation:\u003c\/strong\u003e Higher doses (\u0026gt;500mg\/day) draw on the SAM pool via NNMT. Pair with TMG; consider B-vitamin status review.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI:\u003c\/strong\u003e \u0026lt;5% of users in published trials report mild GI upset, headache, or transient flushing. Typically resolves with food or dose split.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUpper-dose ceiling:\u003c\/strong\u003e Brakedal 2023 NR-SAFE established tolerability of 3000mg\/day for 4 weeks with no serious AEs. Standard daily-foundation dosing is in the 250–1000mg range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-test status:\u003c\/strong\u003e NR is not a banned substance under WADA or NCAA codes. Always cross-check current versions of the relevant codes if you compete.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and manufacturing\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's Liquid NAD+ stick packs are manufactured in a 21 CFR Part 111 cGMP-compliant US facility. Per-batch QC includes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity testing:\u003c\/strong\u003e NR HPLC identity and purity (≥98% spec) confirmed by mass-spec orthogonal verification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; panel (lead, cadmium, mercury, arsenic) at California Proposition 65 thresholds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e USP \u0026lt;467\u0026gt; panel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count, total yeast\/mold, plus pathogen panel for \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eStaph aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e Specification confirmed per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e ≥24-month room-temperature shelf life in foil-laminated single-serve sachets. Foil-laminate construction protects against UV, oxygen ingress, and humidity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergens:\u003c\/strong\u003e No gluten, no dairy, no soy, no nuts. Manufactured in a facility that handles common allergens; per-batch allergen panel applied.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSweeteners:\u003c\/strong\u003e Naturally flavored berry; no artificial colors, no high-fructose corn syrup, no sucralose flood.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-source contract manufacturer audit:\u003c\/strong\u003e Same audited facility across batches, not lowest-bidder rotation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo proprietary blends:\u003c\/strong\u003e Per-stick NR mass disclosed on the supplement-facts panel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much NR is in each stick packet?\u003c\/strong\u003e Per supplement-facts panel on the packaging. Designed to deliver a daily-foundation NR dose in a single stick.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this NR or NMN?\u003c\/strong\u003e NR (Nicotinamide Riboside). For the NMN drink mix, see \u003ca href=\"\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e which combines NR with Resveratrol, PQQ, and Quercetin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with NMN?\u003c\/strong\u003e Yes. Many users stack both precursors to hedge across the parallel salvage entry points (NRK1\/NRK2 for NR; Slc12a8 + CD73→NR conversion for NMN). Pair with TMG for methylation support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Probably not anything dramatic. NAD+ is a cofactor, not a stimulant. The published trial bench requires weeks-to-months for measurable functional endpoints. If you feel a sharp kick, it's likely placebo or an excipient response.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Highly variable. Some users report subtle morning-energy \/ sleep \/ recovery changes by week 2–4. Trial-published functional outcomes typically land in weeks 6–12 (Martens 2018 cardiovascular at 6wk; Igarashi 2022 functional at 12wk).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this at night?\u003c\/strong\u003e You can, but Igarashi 2022 (NMN parallel) found AM \u0026gt; PM dosing on functional endpoints. The mechanism is circadian: SIRT1 has documented co-regulation with BMAL1\/CLOCK (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Morning is the trial-validated time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle?\u003c\/strong\u003e Not required by the published evidence. Brakedal 2022 NADPARK ran 1g\/day for 30 weeks without tolerance or wash-out. Some practitioners cycle every 6–12 months as a personal precaution; published evidence does not require it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrink format vs capsule — which is better?\u003c\/strong\u003e Pharmacokinetically very similar at steady-state (both reach the same NAD+ plateau over weeks). Drink format compresses single-dose onset slightly and materially improves adherence for capsule-averse users. Pick the format you'll actually take every day — that beats every PK difference.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my coffee or breakfast?\u003c\/strong\u003e Yes. NR absorption is not strongly food-dependent. Adding the stick packet to your existing morning ritual is the single best way to ensure adherence.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat does it taste like?\u003c\/strong\u003e Clean berry. No artificial colors, no sucralose flood, no metallic NR aftertaste.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs there caffeine in this?\u003c\/strong\u003e No. This is a pure NAD+ precursor formulation, not an energy drink.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSugar content?\u003c\/strong\u003e Minimal. No added sugar bombs. Check the supplement-facts panel for exact carb\/sugar grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this break a fast?\u003c\/strong\u003e Functionally yes (anything that hits the GI tract breaks autophagy-strict fasting protocols). Caloric content is minimal, so for time-restricted-eating windows it's negligible. For strict autophagy fasts, take during your eating window.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e Yes. No animal-derived ingredients in the powder formulation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGluten free?\u003c\/strong\u003e Yes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrug-test status?\u003c\/strong\u003e NR is not a WADA or NCAA banned substance. Always cross-check current versions of the relevant codes if you compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open multiple packets and dose-split throughout the day?\u003c\/strong\u003e Yes, though daily morning dosing is the trial-validated standard. Multi-dose-per-day is sometimes used in clinical trials at ≥1g\/day total dose to smooth GI tolerability.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during pregnancy?\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy or lactation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during cancer treatment?\u003c\/strong\u003e Coordinate with your oncology team. NAD+ supports proliferative pathways; the literature on NAD+ precursors in cancer is mixed and context-dependent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is this format more expensive per dose than capsules?\u003c\/strong\u003e Single-serve foil-laminated stick packets cost more than HDPE bulk-bottle capsules to produce. The cost is the format, not the active ingredient. If price-per-NR-mg is your primary criterion, the capsule format wins.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with an SSRI \/ antidepressant \/ blood pressure medication?\u003c\/strong\u003e No direct interactions documented. Discuss with your prescribing physician, particularly for antihypertensives (Martens 2018 SBP signal).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with sleep?\u003c\/strong\u003e Indirectly, possibly. SIRT1-BMAL1\/CLOCK circadian interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e) suggest secondary sleep-architecture effects in some users. Direct sleep effects are not the primary positioning — for sleep-first protocols see \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e or \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with hair growth?\u003c\/strong\u003e Indirectly. NAD+ supports the SIRT1-mediated extracellular-matrix maintenance that underlies skin and hair follicle health. For direct hair-cycle support see \u003ca href=\"\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e, \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e, and \u003ca href=\"\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (Rinaldi 2018 anagen-cycle data).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if I miss a day?\u003c\/strong\u003e No problem. Resume next day. NAD+ pathway support is built on sustained consistency over weeks, not single-dose rescue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e Cool, dry, dark. Foil-laminate sachets are stable at room temperature; no refrigeration required. Avoid bathroom storage (humidity).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhere can I see the COA?\u003c\/strong\u003e Per-batch certificate of analysis available on request via our \u003ca href=\"\/pages\/contact\"\u003econtact page\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog — the architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's longevity catalog is structured in concentric layers. NR drink mix (this product) sits in the \u003cstrong\u003eLayer 1 NAD+ Precursor Supply\u003c\/strong\u003e position, alongside our capsule NR and NMN entries. Layer 1 = precursor supply (what feeds NAD+). Layer 2 = sirtuin activators (Resveratrol, Pterostilbene). Layer 3 = methylation + CD38 reduction (TMG, Apigenin, Quercetin, Fisetin). Layer 4 = mitochondrial cofactors (CoQ10, PQQ, Urolithin A, CaAKG). Layer 5 = autophagy + proteostasis (Spermidine). Layer 6 = AMPK pathway (Berberine, ALA). Layer 7 = antioxidant + glutathione (NAC, Glutathione, Glycine, ALA, Liposomal Vit C). Layer 8 = foundational daily (Mg, D3+K2, Omega-3, Curcumin). The right user picks one entry per layer based on goals, format preference, and what's already in the routine. This drink covers Layer 1 in drink format.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — all NAD+ precursors, activators, and convenience formulas\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the 7 daily nutrients underneath every longevity stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the core stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, Ca-AKG\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Fisetin, Quercetin, Apigenin\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — Resveratrol, Omega-3, CoQ10\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — AMPK + glucose-handling layer\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN — morning, empty stomach, or with food\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects — what the research actually shows\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eContext, not endorsement. Citations describe the underlying biology and human-clinical-trial evidence base for NAD+ pathway support; statements about this specific product have not been evaluated by the FDA.\u003c\/em\u003e\u003c\/p\u003e\n\u003cul style=\"font-size:13px;\"\u003e\n  \u003cli\u003eBieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e. 2004;117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eSci Rep\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNat Commun\u003c\/em\u003e. 2018;9(1):1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. \u003cem\u003eAJCN\u003c\/em\u003e. 2018;108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome. \u003cem\u003eCell Reports\u003c\/em\u003e. 2019;28(7):1717–1728.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAJCN\u003c\/em\u003e. 2020;112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy older men. \u003cem\u003eJ Physiol\u003c\/em\u003e. 2021;599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dolle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2022;34(3):396–407.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. A nationwide study of NR-SAFE: a randomized double-blind safety trial of high-dose nicotinamide riboside in Parkinson's disease. \u003cem\u003eNat Commun\u003c\/em\u003e. 2023;14(1):5751.\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2020;31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably. \u003cem\u003eNPJ Aging\u003c\/em\u003e. 2017;3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2017;12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2012;7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2016;23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2011;14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNat Metab\u003c\/em\u003e. 2019;1(1):47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e. 2020;588(7836):174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e. 2008;134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bass GT, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e. 2012;148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e. 2013;62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e. 2018;359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eSekhar RV. GlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(8):e372.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e. 2008;57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eBitterman KJ, Anderson RM, Cohen HY, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. \u003cem\u003eJBC\u003c\/em\u003e. 2002;277(47):45099–45107.\u003c\/li\u003e\n  \u003cli\u003eOlthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2003;133(12):4135–4138.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e · \u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705333432538,"sku":"THP-NAD-LIQUID","price":39.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liquid-nad.jpg?v=1775666212","url":"https:\/\/truehealthprotocol.health\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation","provider":"True Health Protocol","version":"1.0","type":"link"}